by Deliberato Law Center | Jan 27, 2022 | blog, Elder Law, Estate Planning Education, Medicaid, Uncategorized
The Food and Drug Administration (FDA) has approved a drug purported to slow the progress of Alzheimer’s disease. However, the decision is not without controversy. A recent article by AARP explores this subject in some detail. Here is a synopsis. The drug, Aducanumab...
Recent Comments